Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EMEA guidelines for trials in osteoporosis: design implications.

M Boers1

  • 1Department of Clinical Epidemiology & Biostatistics, Free University Hospital, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

The Netherlands Journal of Medicine
|December 17, 2002
PubMed
Summary

Designing clinical trials without a placebo arm presents challenges, particularly for osteoporosis treatments. New European guidelines offer insights into conducting and interpreting these complex drug studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the 'Plants for Joints' randomized controlled trials.

Scandinavian journal of rheumatology·2025
Same author

Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR.

Scandinavian journal of rheumatology·2025
Same author

At the core of measurement - What do you want to measure? And how do you want to measure it? A COSMIN perspective.

Journal of clinical epidemiology·2025
Same author

Longitudinal Speech Outcome at 5 and 10 Years in UCLP: Influence of Speech Therapy and Secondary Velopharyngeal Surgery.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2024
Same author

Scandcleft randomized trials of primary surgery for unilateral cleft lip and palate: Speech proficiency at 10 years of age.

International journal of language & communication disorders·2022
Same author

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study.

Seminars in arthritis and rheumatism·2022

Area of Science:

  • Clinical trial design
  • Pharmacology
  • Osteoporosis research

Background:

  • Trials without placebo arms pose unique design and interpretation challenges.
  • Postmenopausal osteoporosis drug studies often face these complexities.
  • Existing methodologies may require adaptation for non-placebo controlled trials.

Purpose of the Study:

  • To discuss challenges in designing, executing, and interpreting clinical trials lacking a placebo arm.
  • To contextualize these challenges within new European guidelines for osteoporosis drug studies.
  • To provide guidance on navigating non-placebo controlled trial methodologies.

Main Methods:

  • Review of challenges in non-placebo controlled trial methodology.
  • Discussion of European guidelines for osteoporosis drug studies.

Related Experiment Videos

  • Analysis of interpretation issues in trials without placebo arms.

    • Main Results:

    • Trials without placebo arms require careful consideration of design, execution, and interpretation.
    • New European guidelines address specific aspects of osteoporosis drug studies.
    • Methodological adaptations are crucial for valid outcomes in non-placebo controlled trials.

    Conclusions:

    • Designing and interpreting trials without placebo arms is complex but manageable with appropriate strategies.
    • Adherence to new European guidelines can aid in the successful execution of osteoporosis drug studies.
    • Further research into optimizing non-placebo controlled trial designs is warranted.